Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interaction of Solifenacin and Tamsulosin in Healthy Males
NCT02180997Phase 1Completed
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Start
- Jul 2014
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of solifenacin and tamsulosin in benign prostatic hyperplasia (BPH) and overactive bladder (OAB) (6 arms), sponsored by Jeil Pharmaceutical Co., Ltd. Primary endpoints: Area Under the Curve at steady state at 192 hours and Maximum Plasma Concentration at steady state at 192 hours. Started Jul 2014; status: completed.
02
Drugs
solifenacintamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02180997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180997.